These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3923480)

  • 1. Structural effects of substitutions on the p21 proteins.
    Pincus MR; Brandt-Rauf PW
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3596-3600. PubMed ID: 3923480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated conformations of the ras-gene-encoded p21 protein. 1. An energy-refined structure for the normal p21 protein complexed with GDP.
    Dykes DC; Brandt-Rauf P; Luster SM; Chung D; Friedman FK; Pincus MR
    J Biomol Struct Dyn; 1992 Jun; 9(6):1025-44. PubMed ID: 1637501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
    Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
    J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.
    Brandt-Rauf PW; Pincus MR; Carty RP; Lubowsky J; Avitable M; Kung HF; Maizel J
    J Protein Chem; 1989 Feb; 8(1):79-86. PubMed ID: 2669815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein.
    Brandt-Rauf PW; Carty RP; Carucci J; Avitable M; Lubowsky J; Pincus MR
    J Protein Chem; 1988 Aug; 7(4):349-54. PubMed ID: 3076451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the conformation and GTP hydrolysing ability of N-terminal ras p21 protein segments.
    Niu CH; Han KH; Roller PP
    Biochem Biophys Res Commun; 1989 Apr; 160(1):282-8. PubMed ID: 2785386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12.
    Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F
    Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.
    Monaco R; Chen JM; Chung D; Brandt-Rauf P; Pincus MR
    J Protein Chem; 1995 Aug; 14(6):457-66. PubMed ID: 8593186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue.
    Pincus MR; van Renswoude J; Harford JB; Chang EH; Carty RP; Klausner RD
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5253-7. PubMed ID: 6577419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.
    Brandt-Rauf PW; Rackovsky S; Pincus MR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8660-4. PubMed ID: 1978329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins.
    Pincus MR; Brandt-Rauf PW; Carty RP; Lubowsky J; Avitable M; Gibson KD; Scheraga HA
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8375-9. PubMed ID: 3120190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
    Hamer PJ; La Vecchio J; Ng S; DeLellis R; Wolfe H; Carney WP
    Oncogene; 1991 Sep; 6(9):1609-15. PubMed ID: 1923528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the carboxyl terminus of the p21 protein. Structural relationship to the nucleotide-binding/transforming regions of the protein.
    Brandt-Rauf PW; Carty RP; Chen JM; Lee G; Rackovsky S; Pincus MR
    J Protein Chem; 1990 Apr; 9(2):137-42. PubMed ID: 2201311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large differences in the helix propensities of alanine and glycine.
    Chakrabartty A; Schellman JA; Baldwin RL
    Nature; 1991 Jun; 351(6327):586-8. PubMed ID: 2046766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical amino acids of p21 protein are located within beta-turns: further evaluation.
    Murakami M
    J Theor Biol; 1987 Oct; 128(3):339-47. PubMed ID: 3328019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
    Brandt-Rauf PW; Pincus MR; Chen JM
    J Protein Chem; 1989 Dec; 8(6):749-56. PubMed ID: 2576207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric proteins define variable and essential regions of Ha-ras-encoded protein.
    Lowe DG; Ricketts M; Levinson AD; Goeddel DV
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1015-9. PubMed ID: 3277185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
    Carney WP; Hamer P; Petit D; Wolfe H; Cooper G; Lefebvre M; Rabin H
    J Cell Biochem; 1986; 32(3):207-14. PubMed ID: 3536974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of triple-helical structures of collagen peptides containing a Hyp-Thr-Gly, Hyp-Val-Gly, or Hyp-Ser-Gly sequence.
    Okuyama K; Miyama K; Morimoto T; Masakiyo K; Mizuno K; Bächinger HP
    Biopolymers; 2011 Sep; 95(9):628-40. PubMed ID: 21442606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.